Thoratec left ventricular assist device removal after toxic myocarditis.
The clinical manifestation and natural history of myocarditis range is variable from asymptomatic stages to intractable circulatory compromise and death. Supportive therapy is paramount in the treatment of this condition. The use of mechanical circulatory support as bridge-to-recovery or bridge-to-transplantation in cases of cardiovascular collapse is often the only therapeutic option for these patients. We report the case of an adolescent boy with toxic myocarditis, due to cannabis abuse, who was supported with a Thoratec left ventricular assist device (Thoratec Laboratories Corp, Pleasanton, CA) for 96 days before device removal.
Leontiadis
Evangelos
E
Department of Thoracic and Cardiovascular Medicine, Heart and Diabetes Center North-Rhine Westphalia, Ruhr-University of Bochum, Bad Oeynhausen, Germany.
Morshuis
Michiel
M
Arusoglu
Latif
L
Cobaugh
Dagmar
D
Koerfer
Reiner
R
El-Banayosy
Aly
A
D000208:Acute Disease; D000293:Adolescent; D002188:Cannabis / Q000506:poisoning*; D002315:Cardiopulmonary Bypass; D020878:Device Removal / Q000379:methods*; D004867:Equipment Design; D004869:Equipment Safety; D005500:Follow-Up Studies; D006333:Heart Failure / Q000139:chemically induced / Q000601:surgery; D006353:Heart-Assist Devices; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D008297:Male; D009205:Myocarditis / Q000139:chemically induced* / Q000601:surgery*; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D016896:Treatment Outcome